Teva reports second quarter 2023 financial results

Tel aviv, israel--(business wire)--teva pharmaceutical industries ltd. (nyse and tase: teva) today reported results for the quarter ended june 30, 2023. mr. richard francis, teva's president and ceo, said, “teva continued to deliver solid performance this quarter, with revenues coming in at $3.9 billion, up 4% vs. the second quarter of 2022 in local currency terms and non-gaap gross margin up 3.1 percentage points vs. the first quarter of 2023. our growth drivers continue to provide confidence.
TEVA Ratings Summary
TEVA Quant Ranking